Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.56p
   
  • Change Today:
    -0.020p
  • 52 Week High: 5.90p
  • 52 Week Low: 1.09p
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 1,803,036
  • Market Cap: £7.77m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £23,146
Lisa Baderoon 583,963 £9,081
Tim Franklin 525,000 £8,164

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 44,945,948 £698,910
Luca & Associates AG 22,000,000 £342,100
Invesco Ltd 17,872,341 £277,915
Aviva Investors Global 11,285,180 £175,484
Alora Pharmaceuticals LLC 10,909,091 £169,636
M&G Investments 7,600,000 £118,180
Prudential plc 7,600,000 £118,180
Capital Income Builder 4,870,367 £75,734
Dr R Zimmer 4,551,553 £70,777
Odey Asset Management 3,433,319 £53,388
Rhone Trustees (Switzerland) SA 3,386,000 £52,652
Pictet Overseas Trust Corporation Limited 3,287,500 £51,121

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.56p
Change Today -0.020p
% Change -1.27 %
52 Week High 5.90p
52 Week Low 1.09p
Volume 1,803,036
Shares Issued 499.72m
Market Cap £7.77m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 22-Aug-2025

Time Volume / Share Price
16:29 500,876 @ 1.60p
14:35 49,865 @ 1.56p
13:31 60,351 @ 1.56p
12:56 32,256 @ 1.56p
12:27 12,003 @ 1.51p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page